Boehringer Ingelheim 2013 Japan Sales Increase 11% To ¥240 Billion
This article was originally published in PharmAsia News
Executive Summary
Boehringer Ingelheim’s 2013 drug price-based sales in Japan increased 11% to ¥240.1 billion ($2.9 billion) despite the whole market growing only 3.1%, the company announced on April 22.